BioNTech SE
Full profile
Extracted metrics, carbon-efficiency ratios, targets and analysis for BioNTech SE live on the full profile.
Open BioNTech SE's profile →Reports & disclosures
2 documents · 2024–2026 · 1 type
Website
BioNTech: Advancing science to help transform cancer and infectious disease treatments
BioNTech develops mRNA cancer immunotherapies, next-generation immunomodulators and targeted therapies in oncology, and vaccines against infectious diseases.
biontech.com ↗